This slide set is restricted for academic and educational purposes only. Use of the slide set, or of individual slides, for commercial or promotional purposes requires approval from GOLD.
肺阻塞照護新趨勢
高雄醫學大學附設醫院
胸腔內科
鄭孟軒
2024/7/12
1
•Contents:
•病因
•診斷
•治療
•藥物
•非藥物
•疫苗注射
This slide set is restricted for academic and educational purposes only. Use of the slide set, or of individual slides, for commercial or promotional purposes requires approval from GOLD. 2
3
4
Teaching
Slide Set
5
Teaching
Slide Set
6
Teaching
Slide Set
7
Teaching
Slide Set
診斷標準:
FEV1/FVC<0.7
8
9
(preserved ratio impaired spirometry,PRISm)
10
11
12
Teaching
Slide Set
13
評估症狀嚴重度的工具 (mMRCand CAT
score)
Teaching
Slide Set
https://www.cmuh.cmu.edu.tw/NewsInfo/NewsArticle?no=4231 14
GOLD 整合性評估
Teaching
Slide Set
15
穩定期肺阻塞病人使用 CT
•雖然CT 尚未被認為是肺阻塞疾病診斷之必要工具,但是隨著使用的增
加,在肺阻塞病人可以用來評估肺結節以及其他合併的肺疾病
Teaching
Slide Set
16
Teaching
Slide Set
17
LABA/LAMA, 肺復原
ICS
Teaching
Slide Set
18
Teaching
Slide Set
19
20
Teaching
Slide Set
21
台灣目前常用吸入藥物
2021第一次使用吸入器就上手 (修訂版)
22
23
肺阻塞醫療處置循環
24
Teaching
Slide Set
25
Teaching
Slide Set
26
27
28
29
30
31
32
選用吸入器的建議
2021第一次使用吸入器就上手 (修訂版) 33
Teaching
Slide Set
34
肺復原
35
Teaching
Slide Set
36
Teaching
Slide Set
37
Teaching
Slide Set
38
Teaching
Slide Set
39
COPD 患者疫苗建議
Teaching
Slide Set
40
41
COPD或Asthma提升帶狀疱疹及其併發症之風險
1,2
1. Marra F et al. Open Forum Infect Dis 2020 7 :ofaa005 ; 2. Forbes HJ et al. Neurology 2016 87:94 102; 3. Kawai K et al. BMJ Open 2014 4 :e 004833.
帶狀疱疹 風險 疱疹後神經痛 (PHN)風險
†Data from a prospective study involving HZ cases with a median age of 61 years, including patients with COPD (N=5060) and asthma (N=8267); data shows risk of PHN (defined as pain 90 days after HZ, based on diagnostic or prescription
codes) compared with controls without COPD or asthma. Adjusted for age, sex, socioeconomic status, immune deficiencies, comorbidities, smoking, BMI, site of HZ, antivirals and immunosuppressive therapies.
†
42
U.S. CDC/ACIP 帶狀疱疹疫苗接種建議
可用於≥50 歲的成年人 :無論以前是否接種
過水痘疫苗或 ZVL,且不需篩檢水痘病史
即使具帶狀疱疹病史或過去曾接種過 ZVL,
皆需接種兩劑RZV疫苗
接種ZVL後2個月內不應接種 RZV
有帶狀疱疹病史 之成年人應接種 RZV;
且須待帶狀疱疹 急性期過後且症狀減輕始
能接種RZV
https://www.cdc.gov/mmwr/volumes/67/wr/mm6703a5.htm (Accessed August 2022)
HZ:Herpes zoster; CDC:Centers for Disease Control and Prevention
2006 年,美國免疫實踐諮詢委員會 (ACIP) 建議對60 歲
以上的成人常規注射 ZVL,以預防帶狀 疱疹及其併發症,
特別是PHN。然而, RZV 的卓越療效使其在 2018 年被
ACIP 優先推薦用於免疫功能健全的 50 歲以上成年人
Teaching
Slide Set
43
肺氣腫的各種介入治療和手術選擇
Teaching
Slide Set
44
Teaching
Slide Set
45
Teaching
Slide Set
46
Teaching
Slide Set
47
Take home message
•FEV1/FVC< 0.7
•決定治療是否有急性惡化扮演關鍵角色 (≧1 住院,≧2 急性惡化 )
•LABA+LAMA常用起始治療
•Triple therapy(ICS?)➔AEHXwith eosinophil count>100
•Single inhaler
•Keep SpO2> 88 %
•Vaccination
Teaching
Slide Set
48